Abbott Laboratories logo
Abbott Laboratories (ABT)
Compare

ABT Balance Sheet

Assets, liabilities, and equity analysis

ABT Quarterly Balance Sheet (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
Total Current Assets
25.508B25.508B25.996B24.839B24.468B23.153B23.656B23.802B23.119B
6.803B6.803B8.522B7.511B6.951B6.532B7.616B7.558B6.987B
Short-Term Investments
492.000M492.000M417.000M222.000M331.000M312.000M351.000M230.000M232.000M
Cash & Short-Term Investments
7.295B7.295B8.939B7.733B7.282B6.844B7.967B7.788B7.219B
8.210B8.210B7.929B8.138B7.972B7.327B6.925B7.051B6.854B
6.989B6.989B6.488B6.708B6.954B6.639B6.194B6.813B6.814B
Total Assets
110.429B110.429B86.713B84.181B83.999B81.448B81.414B74.356B73.017B
12.377B12.377B12.942B11.504B11.395B10.932B11.733B10.621B10.233B
35.221B35.221B24.035B23.971B23.952B23.359B23.108B23.658B23.308B
Intangible Assets
17.875B17.875B5.526B5.598B5.920B6.261B6.647B7.352B7.827B
Long-Term Investments
1.090B1.090B918.000M951.000M958.000M907.000M886.000M912.000M877.000M
Total Current Liabilities
18.377B18.377B16.496B14.582B13.439B13.004B14.157B14.902B13.760B
4.679B4.679B4.240B4.123B4.306B4.214B4.195B4.034B4.125B
4.409B4.409B3.309B1.345B507.000M506.000M1.754B2.154B1.615B
Total Liabilities
57.728B57.728B33.942B32.917B33.170B32.384B33.513B34.328B33.457B
29.638B29.638B10.827B11.596B12.930B12.736B12.625B12.825B13.139B
34.047B34.047B15.067B12.941B13.437B13.242B15.275B14.979B14.754B
Net Debt (Cash)
27.244B27.244B6.545B5.430B6.486B6.710B7.659B7.421B7.767B
Total Shareholders' Equity
52.061B52.061B52.130B50.954B50.565B48.811B47.664B39.796B39.318B
Common Stock
25.352B25.352B25.527B25.412B25.284B25.125B25.153B25.020B24.858B
49.956B49.956B49.781B49.103B48.467B47.715B47.261B39.056B38.354B
1.391.391.581.701.821.781.671.601.68
0.650.650.290.250.270.270.320.380.38

ABT Annual Balance Sheet (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Current Assets
25.996B23.656B22.670B25.224B24.239B20.441B15.667B14.632B
8.522B7.616B6.896B9.882B9.799B6.838B3.860B3.844B
Short-Term Investments
417.000M351.000M383.000M288.000M450.000M310.000M280.000M242.000M
Cash & Short-Term Investments
8.939B7.967B7.279B10.170B10.249B7.148B4.140B4.086B
7.929B6.925B6.565B6.218B6.487B6.414B5.425B5.182B
6.488B6.194B6.570B6.173B5.157B5.012B4.316B3.796B
Total Assets
86.713B81.414B73.214B74.438B75.196B72.548B67.887B67.173B
12.942B11.733B11.276B10.278B10.112B10.130B8.972B7.563B
24.035B23.108B23.679B22.799B23.231B23.744B23.195B23.254B
Intangible Assets
5.526B6.647B8.815B10.454B12.739B14.784B17.025B18.942B
Long-Term Investments
918.000M886.000M799.000M766.000M903.000M1.031B931.000M897.000M
Total Current Liabilities
16.496B14.157B13.841B15.489B13.105B11.907B10.863B9.012B
4.240B4.195B4.295B4.607B4.408B3.946B3.252B2.975B
3.309B1.754B1.325B2.481B999.000M461.000M1.683B207.000M
Total Liabilities
33.942B33.513B34.387B37.533B39.172B39.545B36.586B36.451B
10.827B12.625B13.599B14.522B17.296B18.527B16.661B19.359B
15.067B15.275B15.873B17.946B19.251B19.890B19.099B19.566B
Net Debt (Cash)
6.545B7.659B8.977B8.064B9.452B13.052B15.239B15.722B
Total Shareholders' Equity
52.130B47.664B38.603B36.686B35.802B32.784B31.088B30.524B
Common Stock
25.527B25.153B24.869B24.709B24.470B24.145B23.853B23.512B
49.781B47.261B37.554B35.257B31.528B27.627B25.847B24.560B
1.581.671.641.631.851.721.441.62
0.290.320.410.490.540.610.610.64

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Abbott Park, IL
114,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert Ford